Robert G. Kramer
2017
In 2017, Robert G. Kramer earned a total compensation of $1.7M as President and Chief Executive Officer at Emergent BioSolutions.
Compensation breakdown
| Non-Equity Incentive Plan | $362,254 |
|---|---|
| Option Awards | $331,054 |
| Salary | $510,107 |
| Stock Awards | $499,973 |
| Other | $8,983 |
| Total | $1,712,371 |
Kramer received $510.1K in salary, accounting for 30% of the total pay in 2017.
Kramer also received $362.3K in non-equity incentive plan, $331.1K in option awards, $500K in stock awards and $9K in other compensation.
Rankings
In 2017, Robert G. Kramer's compensation ranked 6,291st out of 14,666 executives tracked by ExecPay. In other words, Kramer earned more than 57.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,291 out of 14,666 | 57th |
Division Manufacturing | 2,318 out of 5,772 | 60th |
Major group Chemicals And Allied Products | 737 out of 2,075 | 65th |
Industry group Drugs | 570 out of 1,731 | 67th |
Industry Pharmaceutical Preparations | 449 out of 1,333 | 66th |
Source: SEC filing on April 9, 2020.
Kramer's colleagues
We found five more compensation records of executives who worked with Robert G. Kramer at Emergent BioSolutions in 2017.
2017
Daniel Abdun-Nabi
Emergent BioSolutions
Chief Executive Officer
2017
Fuad El-Hibri
Emergent BioSolutions
Chairman
2017
Robert Kramer
Emergent BioSolutions
Chief Financial Officer
2017
Atul Saran
Emergent BioSolutions
General Counsel
2017
Adam Havey
Emergent BioSolutions